Archive · 27 Sep 2025
Indian Market Dips Amid Trade War and FII Outflows
The Indian stock market is currently facing challenges.
The US government has implemented new tariffs on Indian goods, including a large tax on medicine.
Additionally, there is a fee increase for H-1B visas, which is affecting the IT sector.
These issues are causing investors from other countries to sell their stocks, causing the market to go down.
Moreover, the value of the Indian Rupee is decreasing against the US dollar, further discouraging foreign investors, who are now shifting their funds to other markets.
Indian market indices declined for the seventh consecutive session.
Foreign Institutional Investors (FIIs) have been consistently selling Indian stocks.
US tariffs on pharmaceuticals and H-1B visa fee increases are impacting the market.
The falling value of the Indian Rupee against the US Dollar is a concern.
Investors are shifting capital to markets like China and South Korea.
- Who
- Indian Stock Market
- What
- Experienced a decline
- When
- Recent weeks
- Where
- India
- Why
- Due to US tariffs, H-1B visa fees, and FII outflows.
US Trade Policy
Indian Market Response
Key Issues
US Trade Policy
Pushing for higher tariffs and visa restrictions.
Indian Market Response
Experiencing market decline, FII outflows, and rupee depreciation.
- Nifty 50 Decline (7 sessions)
- 3%
- FII Selling (This Month)
- ₹30,141.68 crore
- H-1B Visa Fee Hike
- $1,00,000
- US Tariffs on Pharma
- 100%
- Nifty PE Ratio
- Around 22
Sources
Sensex Today | Stock Market LIVE Updates: Nifty may snap three-week winning run after breaking below key levels
Stocks to buy and sell: From Vedanta to Tata Consumer— Ajit Mishra of Religare Broking picks 3 shares
Buy or sell: Vaishali Parekh recommends three intraday stocks for today — 26 September 2025
Nifty 50, Sensex today: What to expect from Indian stock market in trade on September 26 after Trump tariffs on pharma
Stock market today: Gift Nifty down 18 pts; key levels to watch for Nifty & Nifty Bank
Gold rates in Delhi today, check the rates on 26 September, 2025
US President Donald Trump Announces 100% Tariff On Pharmaceutical Imports From October 1; How Will It Impact Indian Pharma Industry?
Markets slip as Trump’s pharma tariffs, IT concerns weigh on investor sentiment
IT under pressure, Mphasis bucks trend; Trump tariff weighs on pharma: Mayuresh Joshi
Rupee Rebounds From All-Time Low, Rising 6 Paise To 88.70 Against The Dollar Amid Hopes Of India-US Trade Deal Breakthrough
Nifty Prediction Today – September 26, 2025: Nifty futures: Momentum favour bears
Markets extend decline as auto stocks buck trend amid Pharma, IT selloff
3 reasons why the market is falling today: Nifty cracks 1%, Sensex slides 800 points, small and midcaps sell-off
In charts: What Trump's 100% tariff on branded drugs means for India
Small and midcaps selloff: BSE Smallcap plunges 1,000 points, Midcap Index under heavy pressure – Here’s why
Sensex ends 733 points lower, investors lose almost ₹7 lakh crore in a day - 10 key highlights from stock market today
Top Gainers & Losers on Sep 26: Wockhardt, Vodafone Idea, PB Fintech, Eternal, SAIL, Coforge among top losers today
Sensex, Nifty crack for 6th straight session: What dragged markets lower today
Markets crash 0.90% as US slaps 100% tariff on branded drugs
Bears tighten grip on markets; Nifty slips below 24,650
India, US push trade talks amid tariff disputes and oil standoff
IT, pharma drag indices dower, investors’ wealth erodes by Rs 15.2 lakh crore
